Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
365.81
-5.43 (-1.46%)
At close: Jul 10, 2026, 4:00 PM EDT
357.03
-8.78 (-2.40%)
After-hours: Jul 10, 2026, 6:41 PM EDT
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $10.78 billion as of July 10, 2026. Its market cap has increased by 161.87% in one year.
Market Cap
10.78B
Enterprise Value
9.78B
1-Year Change
161.87%
Ranking
Category
Stock Price
$365.81
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $10.78B, an increase of 11,570.98%. That is a compound annual growth rate of 71.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 10.78B | 50.85% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Summit Therapeutics | 12.12B |
| Arrowhead Pharmaceuticals | 12.06B |
| ABIVAX Société Anonyme | 12.00B |
| BioMarin Pharmaceutical | 11.58B |
| Cytokinetics | 11.29B |
| Bio-Techne | 10.99B |
| Apogee Therapeutics | 10.00B |
| Corcept Therapeutics | 9.98B |